Table 7.
Pharmacokinetic properties of top ten ligands with high binding energies.
| S. No | Compound | GI absorption | BBB permeation | Caco-2 permeability | P-glycoprotein substrate | P-glycoprotein inhibitor | Subcellular localization | CYP1A2 inhibitor | CYP2C19 inhibitor | CYP2C9 inhibitor | CYP2D6 inhibitor | CYP3A4 inhibitor | Log KpSkin permeation (cm/s) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Theaflavin-3-3′- digallate | Yes | No | No | No | Yes | Mitochondria | No | No | No | No | No | −9.31 | |
| 2 | Rutin | Yes | No | No | No | No | Mitochondria | No | No | No | No | No | −10.26 | |
| 3 | Hypericin | Yes | No | No | No | No | Mitochondria | Yes | Yes | Yes | No | Yes | −5.32 | |
| 4 | Robustaflavone | Yes | No | No | No | Yes | Mitochondria | Yes | Yes | Yes | No | Yes | −6.01 | |
| 5 | (-)-Solenolide A | Yes | Yes | No | Yes | Yes | Mitochondria | No | No | No | No | No | −7.32 | |
| 6 | Rhusflavone | Yes | No | No | No | Yes | Mitochondria | Yes | Yes | Yes | No | Yes | −6.42 | |
| 7 | Ginkgetin | Yes | No | No | No | Yes | Mitochondria | Yes | Yes | Yes | No | Yes | −5.72 | |
| 8 | Rhinacanthin E | Yes | Yes | Yes | No | Yes | Mitochondria | Yes | Yes | Yes | No | Yes | −6.45 | |
| 9 | Sorbarin | Yes | No | No | No | No | Mitochondria | No | No | No | No | No | −8.22 | |
| 10 | Betulinic acid | Yes | No | No | No | No | Mitochondria | No | No | No | No | No | −3.26 | |